CVN-636

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H20FNO4S
Molecular Weight	377.43
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](C(=O)N[C@H]1COC2=CC=CC=C2[C@@H]1S(C)(=O)=O)C3=CC=C(F)C=C3

InChI

InChIKey=DKLUNKKXISSMIY-IWEFOYFVSA-N

InChI=1S/C19H20FNO4S/c1-12(13-7-9-14(20)10-8-13)19(22)21-16-11-25-17-6-4-3-5-15(17)18(16)26(2,23)24/h3-10,12,16,18H,11H2,1-2H3,(H,21,22)/t12-,16-,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H20FNO4S
Molecular Weight	377.43
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 19:47:56 GMT 2023` Edited by `admin` on `Sat Dec 16 19:47:56 GMT 2023`
Record UNII	EY764XW2YM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CVN-636

Code

English

(αS)-N-[(3S,4S)-3,4-Dihydro-4-(methylsulfonyl)-2H-1-benzopyran-3-yl]-4-fluoro-α-methylbenzeneacetamide

Systematic Name

English

CVN636

Code

English

Benzeneacetamide, N-[(3S,4S)-3,4-dihydro-4-(methylsulfonyl)-2H-1-benzopyran-3-yl]-4-fluoro-α-methyl-, (αS)-

Systematic Name

English

Code System Code Type Description

FDA UNII

EY764XW2YM

Created by admin on Sat Dec 16 19:47:56 GMT 2023 , Edited by admin on Sat Dec 16 19:47:56 GMT 2023

PRIMARY

CAS

2226732-62-1

Created by admin on Sat Dec 16 19:47:56 GMT 2023 , Edited by admin on Sat Dec 16 19:47:56 GMT 2023

PRIMARY

PUBCHEM

134521670

Created by admin on Sat Dec 16 19:47:56 GMT 2023 , Edited by admin on Sat Dec 16 19:47:56 GMT 2023

PRIMARY

Related Record Type Details


					TK3R779E2A

METABOTROPIC GLUTAMATE RECEPTOR 7

TARGET -> AGONIST

Comments:

Does not lead to significant desensitization or downregulation of receptor.

Interaction Type:

ALLOSTERIC ACTIVATOR

Qualification:

EC50

Amount:

Related Record Type Details


					EY764XW2YM

CVN-636

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
BRAIN/PLASMA RATIO	PHARMACOKINETIC				Kp,uu PHARMACOKINETIC